Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines.
10.3346/jkms.2014.29.2.164
- Author:
Soo Mee BANG
1
;
Moon Ju JANG
;
Kyoung Ha KIM
;
Ho Young YHIM
;
Yeo Kyeoung KIM
;
Seung Hyun NAM
;
Hun Gyu HWANG
;
Sung Hwa BAE
;
Sung Hyun KIM
;
Yeung Chul MUN
;
Yang Ki KIM
;
Inho KIM
;
Won Il CHOI
;
Chul Won JUNG
;
Nan Hee PARK
;
Nam Kyong CHOI
;
Byung Joo PARK
;
Doyeun OH
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Publication Type:Review ; Practice Guideline
- Keywords:
Guideline;
Prevention;
Venous Thromboembolism;
Bleeding
- MeSH:
Age Factors;
Anticoagulants/adverse effects/*therapeutic use;
Asian Continental Ancestry Group;
Evidence-Based Medicine;
Heparin, Low-Molecular-Weight/therapeutic use;
Humans;
*Mechanical Thrombolysis;
Neoplasms/complications/surgery;
Republic of Korea;
Risk Assessment;
Surgical Procedures, Operative/adverse effects;
Venous Thromboembolism/etiology/prevention & control/*therapy
- From:Journal of Korean Medical Science
2014;29(2):164-171
- CountryRepublic of Korea
- Language:English
-
Abstract:
In 2010, we proposed the first Korean Guidelines for the Prevention of Venous Thromboembolism (VTE). It was applicable to Korean patients, by modifying the contents of the second edition of the Japanese guidelines for the prevention of VTE and the 8th edition of the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines. From 2007 to 2011, we conducted a nationwide study regarding the incidence of VTE after major surgery using the Health Insurance Review and Assessment Service (HIRA) database. In addition, we have considered the 9th edition of the ACCP Evidenced-Based Clinical Practice Guidelines, published in 2012. It emphasized the importance of clinically relevant events as opposed to asymptomatic outcomes with preferences for both thrombotic and bleeding outcomes. Thus, in the development of the new Korean guidelines, three major points were addressed: 1) the new guidelines stratify patients into 4 risk groups (very low, low, moderate, and high) according to the actual incidence of symptomatic VTE from the HIRA databases; 2) the recommended optimal VTE prophylaxis for each group was modified according to condition-specific thrombotic and bleeding risks; 3) guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and/or physician advice.
